ESS
42
2
CTAS
50
2
ADP
70
2
CHRW
68
-3
HON
70
-9
AEP
64
2
KO
54
2
GIS
47
-2
GE
71
3
DOW
47
-3
EXR
57
2
BIIB
53
-2
HIG
66
3
FOXA
66
3
CB
57
3
CRM
59
5
KMB
37
-2
AZO
59
3
COST
50
2
AON
65
2
ESS
42
2
CTAS
50
2
ADP
70
2
CHRW
68
-3
HON
70
-9
AEP
64
2
KO
54
2
GIS
47
-2
GE
71
3
DOW
47
-3
EXR
57
2
BIIB
53
-2
HIG
66
3
FOXA
66
3
CB
57
3
CRM
59
5
KMB
37
-2
AZO
59
3
COST
50
2
AON
65
2
Financhill
Back

Mitek Systems Vs. Blueprint Medicines Industry Stock Comparison

Buy
54

MITK
Mitek Systems

Last Price:
$10.38
Seasonality Move:
10.6%
Sell
50

BPMC
Blueprint Medicines

Last Price:
$128.39
Seasonality Move:
6.28%
Buy
54
Mitek Systems (MITK) is a Buy

Is Mitek Systems a Buy, Sell or Hold?

  • The current Mitek Systems [MITK] share price is $10.35. The Score for MITK is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • MITK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $128.35. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MITK Stock Price Chart

What is Mitek Systems's stock price today?

  • The Mitek Systems share price today is $10.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MITK is experiencing slight selling pressure.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $128.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.

MITK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 65.4 Buy
Chaikin Money Flow: -64108 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.53 - 10.15) Buy
Bollinger Bands (100): (8.3 - 9.96) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.65 Buy
Relative Strength Index (14 RSI): 74.59 Buy
Chaikin Money Flow: 675123 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (119 - 133.06) Buy
Bollinger Bands (100): (84.56 - 117) Buy

MITK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10 Buy
20-day SMA: 9.94 Buy
50-day SMA: 9.43 Buy
200-day SMA: 9.31 Buy
8-day EMA: 10.06 Buy
20-day EMA: 9.88 Buy
50-day EMA: 9.54 Buy
200-day EMA: 9.61 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.23 Buy
20-day SMA: 128.14 Buy
50-day SMA: 111.57 Buy
200-day SMA: 97.6 Buy
8-day EMA: 128.16 Buy
20-day EMA: 125.23 Buy
50-day EMA: 115.07 Buy
200-day EMA: 100.77 Buy

Mitek Systems Earnings Growth & MITK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.12 per share, an increase this year of $0.07 per share, and an increase next year of $0.14 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

Mitek Systems Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):